App Intel

MelApp

LiveMeeter Congressi SRL5 apps · 39.8K installsMedicalFreeit.meeter.melapp

Identify T, N, M and S params of melanoma, guiding you through the AJCC tables.

Alert me★ WatchOpen in Play ↗
Total installs
3,014
exact · Play shows 1,000+
Installs / day
0
since last crawl
Rating
—★
— ratings · — reviews
Released
22 Nov 2019
6.9y ago
Last update
21 May 2025
v1.2.18 · 1.4y ago
Countries
—
not checked yet

Install history

exact counter from Google Play
2.9K3.5K4K4.5K5K11 Oct12 Oct12 Oct
2.9K3.5K4K4.5K5K11 Oct12 Oct12 Oct

Installs per day · last 90 days

Not enough history yet — check back tomorrow

Change timeline

No changes recorded yet. We compare every crawl with the previous one and list title, icon, screenshots, description, version, price and availability changes here.

Country availability

Availability has not been checked for this app yet. “Check all countries” looks the app up in about 140 Google Play storefronts and shows where it is live, listed but not installable, or missing — plus any country-specific (custom) store listings.

Top countries

Country data will be available soon.

We estimate where downloads come from using the app’s position in Google Play’s top charts in about 140 countries. This app is not in any chart we have collected yet; the estimate appears as soon as it is.

Top chart positions

Not in any tracked top chart.

App manifest

Read this app's manifest from Google Play: permissions, declared SDKs, components and AdMob app ID. Saved analysis appears here automatically.

Manifest analysis reads only the required APK ranges. Base APK downloads may need separate device splits to install.

Data safety

declared by the developer on Google Play
  • No data shared with third parties
  • Collects data Health and fitness
  • Data is encrypted in transit
  • No way to ask for data deletion

This is the developer's own declaration, summarised from the Play listing. The permissions below show what the app is technically able to access.

Permissions

1 in 1 group
0 Sensitive0 Notable1 Routine
OtherRoutine1

Access to miscellaneous device features that don't fit other categories

  • Connect to the internet to load content and send datafull network access · INTERNET

Sensitive = can reach personal data, location, camera/mic or act on your behalf. Notable = changes how your device behaves. Routine = normal for almost every app. Source: Google Play's permission list for all versions of this app.

Store listing

Full description
Identify rapidly and accurately T, N, M parameters for melanoma staging, guiding you through the complex AJCC tables. Correct staging of melanoma is of fundamental importance for the correct treatment of patients suffering from this condition. In 2018, the eighth edition of the American Joint Committee on Cancer (AJCC) T-N-M classification came into effect to improve the prognostic stratification of melanoma. Calculating the stage of melanoma may not be easy. MelApp is a supporting app that helps you navigate quickly and accurately through the complex AJCC tables. By simply selecting items from a drop-down menu, set according to the criteria of the AJCC tables, MelApp also allows you to identify the three T-N-M parameters. By cross-referencing the three values thus obtained, the final result, parameter S, will help you determine the stage of the lesion as identified by the AJCC tables and suggest possible follow-up indications. MelApp is developed by Meeter Congressi in collaboration with Melanoma Unit - University of Campania "Luigi Vanvitelli", Prof. Giuseppe Argenziano, Dr. Elvira Moscarella, Dr. Gabriella Brancaccio and Dr. Teresa Russo. Meeter Congressi and Melanoma Unit have developed MelApp based on the information contained in the AJCC Cancer Staging Manual. The definitions used are copyrighted by AJCC. We are not responsible for the academic accuracy or thoroughness of the information contained in the AJCC Cancer Staging Manual. Meeter Congressi and Melanoma Unit shall not be held liable for any damages arising out of the use of the information contained in MelApp, for any injury or damage to persons or property resulting from the use of the app or any of its features, including lost profits, punitive or exemplary damages, since it serves only as guidance support for the AJCC tables. MelApp is an entertainment tool for health care worker education and is not a diagnostic and therapeutic resource. MelApp is not a medical device. MelApp should not be used for the diagnosis or treatment of melanoma. Only a doctor can diagnose or treat melanoma. Possible follow-up indications are for guidance only. Only a doctor can diagnose or treat melanoma. MelApp is not intended to replace the results of the patient's medical history and objective examination.

Growing in Medical

Category →